Publications

Find at Harvard

Register to Read

June 2011
Teaching Note

Novasys Medical (TN)

By: Richard G. Hamermesh

Teaching Note for 810027. View Details

Keywords: Product Development; Health Care and Treatment; Policy; Medical Devices and Supplies Industry

03 Mar 2015
First Look

First Look: March 3

Abstract—Improving the way we pay for health care must be a central component in health care reform. Payment reform must link provider... View Details

Keywords: Sean Silverthorne

17 Jan 2012
First Look

First Look: January 17

reference points or anchors to simplify the complex tasks of valuation and negotiation. Read the paper: http://people.hbs.edu/mbaker/cv/papers/refpt.pdf The Four Habits of High-Value Health Care... View Details

Keywords: Sean Silverthorne

2024
Working Paper

Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances

By: Amar Bhidé and Srikant M. Datar

In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details

Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms

SSRN

Read Now

January 2018
Case

Spark Therapeutics: Pioneering Gene Therapy

By: Robert F. Higgins and Tina Liu

Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details

Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy

April 2017
Supplement

Imprimis (C)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel

This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details

Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States

February 2024
Teaching Note

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul

Teaching Note for HBS Case No. 724-412. View Details

Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Care and Treatment; Pharmaceutical Industry; Europe; United States; United Kingdom

March 2016
Case

Residency Select or J3Personica?

By: William Kerr and Kathryn S. Roloff

Residency Select, LLC provides psychometric assessments for matching medical students to residency programs. After a series of successful pilots, founder Alan Friedman is considering whether to continue developing his offerings in this area, or whether to expand into... View Details

Keywords: Marketplace Matching; Expansion; Higher Education; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Service Industry

April 2024 (Revised July 2024)
Case

Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs

By: Joseph L. Badaracco, Tom Quinn and John Schultz

Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details

02 May 2008
What Do You Think?

What is the Future of State Capitalism?

the World Trade Organization. C. J. Cullinane comments, "We need ... global guidelines and regulations as well as transparency." Jacoline Loewen, concurs, saying that "there may not be global rules for State Capitalism yet,... View Details

Keywords: by Jim Heskett

14 Feb 2012
First Look

First Look: February 14

individuals bring well-articulated preexisting preferences to such decisions. Understanding beliefs and attitudes motivating these preferences can assist physicians in helping parents make informed decisions consistent with their values. Consumer-Driven View Details

Keywords: Carmen Nobel

20 Jun 2017
First Look

First Look at New Research and Ideas, June 20

School Case 317-103 PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World PharmAccess is an Amsterdam-based NGO working to support the development of the private health View Details

Keywords: Sean Silverthorne

July–August 2018
Article

Using Time-Driven Activity-Based Costing to Model the Costs of Various Process-Improvement Strategies in Acute Pain Management

By: Keyuri Popat, Kelly Ann Gracia, Alexis B. Guzman and Thomas W. Feeley

Pain control for patients undergoing thoracic surgery is essential for their comfort and for improving their ability to function after surgery, but it can significantly increase costs. Here, we demonstrate how time-driven activity-based costing (TDABC) can be used to... View Details

Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost Management; Performance Improvement

Find at Harvard

Register to Read

04 May 2007
What Do You Think?

How Do Managers Think?

Summing Up Can managers acquire ways of thinking or ways of learning from doctors? Managers can learn from an understanding of how doctors think. But whether the lessons are profound or even totally applicable was a matter of discussion among respondents to this... View Details

Keywords: by Jim Heskett

August 2017
Article

Tort Reform and Innovation

By: Alberto Galasso and Hong Luo

Current academic and policy debates focus on the impact of tort reforms on physicians’ behavior and medical costs. This paper examines whether these reforms also affect incentives to develop new technologies. We develop a theoretical model that predicts that the impact... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technological Innovation; Legal Liability; Medical Devices and Supplies Industry

Find at Harvard

Read Now

02 Aug 2016
First Look

August 2, 2016

Healthcare Partners Inc. (DaVita), in August 2013. The two would discuss whether Golomb should lead a new DaVita venture, Paladina Health (Paladina), which operated a network of primary care clinics. DaVita... View Details

Keywords: Sean Silverthorne

May 2025
Teaching Note

The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation

By: Tsedal Neeley

Teaching Note for HBS Case No. 425-720. Florian Hillen, co-founder and CEO of VideaHealth, a startup using artificial intelligence (AI) to detect dental conditions on x-rays, spent the early years of his company laying the groundwork for an AI factory. This AI factory,... View Details

Keywords: Diagnostics; Organization Design; Change Management; Disruption; Transformation; Health Care and Treatment; AI and Machine Learning; Technological Innovation; Technology Adoption; Management Style; Organizational Culture; Success; Health Industry; Health Industry; United States

04 May 2010
First Look

First Look: May 4

health concerns can communicate with physicians online or by phone and receive advice or even a diagnosis without having to visit the physician's office. American Well's co-founders, Ido Schoenberg and Roy Schoenberg, believe this... View Details

Keywords: Martha Lagace

August 2008 (Revised September 2008)
Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details

Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States